DMAAU NASDAQ
Drugs Made In America Acquisition Corp. Units
1W: +3.0%
1M: +3.0%
3M: +3.3%
YTD: +3.7%
1Y: +8.2%
$10.90
+0.00 (+0.00%)
Weekly Expected Move ±0.5%
$11
$11
$11
$11
$11
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$255.4M
52W Range10.25-12.5
Volume11,060
Avg Volume95
Beta0.09
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEORoger Bendelac
Employees2
SectorFinancial Services
IndustryFinancial - Conglomerates
IPO Date2025-01-27
Websitedmaacorp.com
1 East Broward Boulevard, Suite 700â
Fort Lauderdale, FL 33301
US
Fort Lauderdale, FL 33301
US
(954) 870-3099
About Drugs Made In America Acquisition Corp. Units
Drugs Made In America Acquisition Corp. is a blank check company. It is an exempt company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The company was founded on May 23, 2024 and is headquartered in Fort Lauderdale, FL.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Drugs Made In Americ | P-Purchase | 30,000 | — | 2025-02-18 |
| Drugs Made In Americ | P-Purchase | 30,000 | — | 2025-02-18 |
| Stockwell Lynn | P-Purchase | 30,000 | — | 2025-02-18 |
| Stockwell Lynn | P-Purchase | 30,000 | — | 2025-02-18 |
| Drugs Made In Americ | P-Purchase | 400,000 | — | 2025-01-29 |